Call for Abstracts

The Organizing Committee invites authors to submit abstracts

Call for Abstracts

SUBMISSION DEADLINE:  February 28, 2017  (11:59 pm EST)

The Organizing Committee invites authors to submit abstracts to be considered for inclusion in the Scientific Program for either oral or poster presentations. Abstracts should include only original data. Case reports must be submitted for poster presentation.

The conference sessions will be organized around the three major themes of Diagnosis, Treatment, and Mechanism.  Within each of these themes we will bring together basic scientists and clinicians, in the hope of stimulating and educating both.  Questions that the organizing committee is especially interested to see addressed by submitted abstracts include, but are not limited to:

  • What are the risk factors and mechanisms for AVM formation in HHT?
  • What are the downstream mediators of ALK1 and ENG?
  • How are ALK1 and ENG activity regulated?
  • What are the roles of endothelial cell, pericyte and other cellular interactions in HHT?
  • Can enhancement of ALK1 or ENG expression treat HHT?
  • What is the role/future of stem cells in HHT?
  • Are all AVM present in some form at birth?
  • What are the mechanisms and risk factors for AVM growth?
  • What causes the differing clinical manifestations of ALK1 and ENG?
  • Is immune function altered in HHT and what are the clinical ramifications?
  • Is uterine bleeding increased in HHT and what are the causes?
  • How can we best prevent reperfusion/recanalization of AVMs?
  • What are the ideal screening and monitoring programs for AVMs in children and adults?
  • How can we better sort out variants of unknown significance in HHT?
  • Which treatments are truly effective in prevention of bleeding in HHT?
  • Can we predict which patients will respond to specific HHT therapies?
  • What are the best cell and animal models for testing new drugs in HHT?
  • How does pregnancy affect AVM development and growth?
  • What is the optimal treatment algorithm for nosebleeds in HHT?

Abstract Guidelines

  1. Abstract must be written in English.
  2. The abstract should be organized as follows: Title; Authors; Affiliation; Objectives; Methods; Results; Conclusions.
  3. Abstract Titles should be in capital letters.
  4. Authors’ names should be in boldface and listed in the following order: last name, first initial, degree.
  5. All authors should be listed and the presenting author’s name should be underlined.
  6. Authors’ affiliations should be listed in the following order: department, institution, city, state, and country.
  1. The abstract text should be a maximum of 250 words (not including title, authors, or affiliations) and should include sections on objectives, methods, results, and conclusions.
  2. Font 12 pt Arial, single spaced, 1″ margins.
  3. There is no limit to the number of abstracts a presenter can submit, but the scientific committee expects that all abstracts selected for presentation will be presented by the first author.
  4. The submitter can choose their preference of presentation type – oral or poster – but the final decision will be up to the Organizing Committee. Abstracts will be reviewed and scored based on actual results reported in the abstract; abstracts without any data will receive a lower score.  Case reports will only be selected for poster presentations.

Outstanding Oral Presentation and Poster Awards

Outstanding Oral Presentation and Poster Awards will be presented to Residents, Postdoctoral/Clinical Fellows, PhD Candidates or Early Stage Investigators for outstanding presentation of their abstracts. Awardees are selected on site and award recipients will be announced during the last session on Sunday, June 11, 2017. These awards include a certificate and monetary award of $250.00 (US).

Up to eight awards will be given in these categories:

  • Best Clinical Oral Presentation
  • Best Scientific Oral Presentation
  • Best Clinical Poster Presentation
  • Best Scientific Poster Presentation

Travel Awards

Cure HHT will be granting Travel Awards for ten (10) abstract oral presenters to attend the 12th HHT International Scientific Conference. Awardees are selected based upon their abstract score and award recipients be announced by April 15, 2017. Award recipients will receive $750.00 (US) upon arrival at the conference to apply toward their travel and hotel costs. 

Learn More

Abstract Deadline

February 28, 2017 (11:59pm eastern time)

Submit Abstract

Abstract Deadline: February 28, 2017

Contact

Nicole Schaefer
Director, Professional & Medical Programs

Email: conference@curehht.org

Phone: 410-357-9932 (US)